SELECTA BIOSCIENCES INC License Agreements

9 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Patent License Agreement, between Cartesian Therapeutics, Inc. and the U.S. Department of Health and Human Services, as represented by the National Cancer Institute of the...
License Agreements
SELECTA BIOSCIENCES INC
2024
License and Development Agreement, dated January 8, 2023, by and between Selecta Biosciences, Inc. and Audentes Therapeutics, Inc
License Agreements
SELECTA BIOSCIENCES INC
2024
Patent License Agreement by and between Biogen MA, Inc. and Cartesian Therapeutics, Inc., dated September 8, 2023
License Agreements
SELECTA BIOSCIENCES INC
2024
Amendment No. 1 to License and Development Agreement, dated as of October 31, 2023, by and between the Registrant and Swedish Orphan Biovitrum AB (Publ)
License Agreements
SELECTA BIOSCIENCES INC
2024
License and Development Agreement, dated as of June 11, 2020, by and between the Registrant and Swedish Orphan Biovitrum AB (Publ)
License Agreements
SELECTA BIOSCIENCES INC
Biotechnology
DE
2020
Fifth Amendment to Exclusive Patent License Agreement, dated as of May 15, 2020, by and between the Registrant and the Massachusetts Institute of Technology
License Agreements
SELECTA BIOSCIENCES INC
Biotechnology
2020
Fourth Amendment to Exclusive Patent License Agreement, entered into on December 13, 2019, by and between the Massachusetts Institute of Technology and the Registrant
License Agreements
SELECTA BIOSCIENCES INC
Biotechnology
2020
Feasibility Study and License Agreement by and between Asklepios BioPharmaceutical, Inc. and Selecta Biosciences, Inc. dated August 6, 2019
License Agreements
SELECTA BIOSCIENCES INC
Biotechnology
DE
2019
AMENDED & RESTATED LICENSE AGREEMENT
License Agreements
SELECTA BIOSCIENCES INC
Biotechnology
NY
2017